X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Endocrine Metabolic & Immune Disorders-Drug Targets

期刊標題檢索 ENDOCR METAB IM 最新評論: The number of papers published each year is low, so it is not easy to ... (2018-08-28)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Endocrine Metabolic & Immune Disorders-Drug Targets]您好,您是該頁面的第 20779 位訪客。

期刊簡介
期刊名稱Endocrine Metabolic & Immune Disorders-Drug Targets Endocrine Metabolic & Immune Disorders-Drug Targets
LetPub Score
5.3
50 ratings
Rate

Reputation
6.3

Influence
3.8

Speed
8.5

期刊簡稱ENDOCR METAB IMMUNE
ISSN1871-5303
E-ISSN2212-3873
h-index44
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.600.4950.541
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q2119 / 244
Category: Medicine
Subcategory: Immunology and Allergy
Q3131 / 233

自引率 (2023-2024)5.00%自引率趨勢
掲載範囲
Aims & Scope

This journal is devoted to timely reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome.
官方網站http://benthamscience.com/journal/index.php?journalID=emiddt
在線稿件提交http://bsp-cms.eurekaselect.com/index.php/CDTIEMD
開放訪問No
出版商Bentham Science Publishers B.V.
主題領域ENDOCRINOLOGY & METABOLISMIMMUNOLOGY
出版國/地區U ARAB EMIRATES
發行頻率
創刊年0
每年文章數176每年文章數趨勢
黃金OA百分比1.65%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ3134/186
IMMUNOLOGYSCIEQ4144/181
PHARMACOLOGY & PHARMACYSCIEQ3222/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1871-5303%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Endocrine Metabolic & Immune Disorders-Drug Targets】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Science ImmunologyH-index: 0

    CiteScore: 32.90
    Journal of Allergy and Clinical Immunology-In PracticeH-index: 40

    CiteScore: 11.10
    Cancer Immunology ResearchH-index: 62

    CiteScore: 15.60
    npj VaccinesH-index: 8

    CiteScore: 11.90
    OncoImmunologyH-index: 58

    CiteScore: 12.80
    OncoImmunologyH-index: 49

    CiteScore: 12.80
    ALLERGOLOGY INTERNATIONALH-index: 45

    CiteScore: 12.60
    HLAH-index: 93

    CiteScore: 3.00
    Immunity & AgeingH-index: 38

    CiteScore: 10.20
    Clinical and Translational AllergyH-index: 28

    CiteScore: 7.50
    學科內最受檢索的期刊 頁面查看次數
    Journal of Inflammation Research74002
    Cancer Immunology Research57106
    OncoImmunology54803
    OncoImmunology50218
    Science Immunology39870
    npj Vaccines29223
    Human Vaccines & Immunotherapeutics24480
    Human Vaccines & Immunotherapeutics24446
    Journal of Allergy and Clinical Immunology-In Practice18703
    Allergy Asthma & Immunology Research18484
  •  

    Endocrine Metabolic & Immune Disorders-Drug Targets Endocrine Metabolic & Immune Disorders-Drug Targets
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Endocrine Metabolic & Immune Disorders-Drug Targets] 的評論撰寫評論
作者: YSL


領域: 医学
審稿時間: 5.0 month(s)
結果: 修改後接受


撰寫評論

2018-08-28 17:42:03 評論於
The number of papers published each year is low, so it is not easy to get accepted here. The reviewers asked some questions that are not easy to answer.

(0) 讚! | YSL

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Endocrine Metabolic & Immune Disorders-Drug Targets] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*